Celiac disease and non-celiac gluten sensitivity – characteristics and differences
DOI:
https://doi.org/10.12775/JEHS.2023.26.01.007Keywords
Celiac disease, non-celiac gluten sensitivity, allergy, diet, FODMAPAbstract
Introduction
Celiac disease is a quite common condition resulting from the interaction of genetic, immunological, and environmental factors, with the main environmental factor being exposure to gluten. Non-celiac gluten sensitivity (NCGS) affects individuals without celiac disease or wheat allergy and is characterized by intestinal and extraintestinal symptoms related to the consumption of grain products, without accompanying damage to the intestinal mucosa.
Discussion
Gluten is a grain protein that is resistant to digestive enzymes and accumulates in the intestines, leading to tissue damage and the release of tissue transglutaminase 2 (tTG2) enzyme, which increases gluten immunogenicity. The presence of HLA-DQ2 or HLA-DQ8 gene variants in the genome is a necessary condition for the development of the disease, but it does not always lead to celiac disease. The pathomechanism of non-celiac gluten sensitivity is not yet fully understood. Diagnosis of celiac disease involves serological tests, genetic tests, and histological examination.
Conclusions
The only effective treatment for celiac disease is a strict gluten-free diet, which involves eliminating wheat, rye, barley, and triticale from one's diet. Further research is necessary to search for effective therapies. The approach for NCGS involves introducing an appropriate diet - either low FODMAP or gluten-free.
References
Fasano A, Catassi C. Current approaches to diagnosis and treatment of celiac disease: An evolving spectrum. Gastroenterology. 2001 Feb 1;120(3):636–51.
Lionetti E, Catassi C. New Clues in Celiac Disease Epidemiology, Pathogenesis, Clinical Manifestations, and Treatment. Int Rev Immunol. 2011 Jul 29;30(4):219–31.
Singh P, Arora A, Strand TA, Leffler DA, Catassi C, Green PH, et al. Global Prevalence of Celiac Disease: Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2018 Jun 1;16(6):823-836.e2.
World Gastroenterology Organisation Global Guidelines - Celiac Disease, February 2017: Erratum. J Clin Gastroenterol. 2019 Apr;53(4):313.
Catassi C, Elli L, Bonaz B, Bouma G, Carroccio A, Castillejo G, et al. Diagnosis of Non-Celiac Gluten Sensitivity (NCGS): The Salerno Experts’ Criteria. Nutrients. 2015 Jun;7(6):4966–77.
choroba_trzewna.pdf (Internet). (cited 2023 Apr 2). Available from: http://www.celiakia.pl/images/stories/choroba_trzewna.pdf
Shewry PR, Halford NG. Cereal seed storage proteins: structures, properties and role in grain utilization. J Exp Bot. 2002 Apr 15;53(370):947–58.
Shan L, Qiao SW, Arentz-Hansen H, Molberg Ø, Gray GM, Sollid LM, et al. Identification and Analysis of Multivalent Proteolytically Resistant Peptides from Gluten: Implications for Celiac Sprue. J Proteome Res. 2005 Oct 1;4(5):1732–41.
Matysiak-Budnik T, Moura IC, Arcos-Fajardo M, Lebreton C, Ménard S, Candalh C, et al. Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease. J Exp Med. 2007 Dec 31;205(1):143–54.
Nisticò L, Fagnani C, Coto I, Percopo S, Cotichini R, Limongelli MG, et al. Concordance, disease progression, and heritability of coeliac disease in Italian twins. Gut. 2006 Jun 1;55(6):803–8.
Mearin ML, Biemond I, Peña AS, Polanco I, Vazquez C, Schreuder GT, et al. HLA-DR phenotypes in Spanish coeliac children: their contribution to the understanding of the genetics of the disease. Gut. 1983 Jun 1;24(6):532–7.
Gutierrez-Achury J, Coutinho de Almeida R, Wijmenga C. Shared genetics in coeliac disease and other immune-mediated diseases. J Intern Med. 2011;269(6):591–603.
Tjon JML, van Bergen J, Koning F. Celiac disease: how complicated can it get? Immunogenetics. 2010 Oct 1;62(10):641–51.
Meresse B, Chen Z, Ciszewski C, Tretiakova M, Bhagat G, Krausz TN, et al. Coordinated Induction by IL15 of a TCR-Independent NKG2D Signaling Pathway Converts CTL into Lymphokine-Activated Killer Cells in Celiac Disease. Immunity. 2004 Sep 1;21(3):357–66.
Shahbazkhani B, Fanaeian MM, Farahvash MJ, Aletaha N, Alborzi F, Elli L, et al. Prevalence of Non-Celiac Gluten Sensitivity in Patients with Refractory Functional Dyspepsia: a Randomized Double-blind Placebo Controlled Trial. Sci Rep. 2020 Feb 12;10(1):2401.
Alvisi P, De Fazio L, Valerii MC, Cavazza E, Salerno A, Lacorte D, et al. Responses of blood mononucleated cells and clinical outcome of non-celiac gluten sensitive pediatric patients to various cereal sources: a pilot study. Int J Food Sci Nutr. 2017 Nov 17;68(8):1005–12.
Valerii MC, Ricci C, Spisni E, Di Silvestro R, De Fazio L, Cavazza E, et al. Responses of peripheral blood mononucleated cells from non-celiac gluten sensitive patients to various cereal sources. Food Chem. 2015 Jun 1;176:167–74.
Carroccio A, Giannone G, Mansueto P, Soresi M, Blasca FL, Fayer F, et al. Duodenal and Rectal Mucosa Inflammation in Patients With Non-celiac Wheat Sensitivity. Clin Gastroenterol Hepatol. 2019 Mar 1;17(4):682-690.e3.
Zanini B, Villanacci V, Marullo M, Cadei M, Lanzarotto F, Bozzola A, et al. Duodenal histological features in suspected non-celiac gluten sensitivity: new insights into a still undefined condition. Virchows Arch Int J Pathol. 2018 Aug;473(2):229–34.
Losurdo G, Piscitelli D, Pezzuto F, Fortarezza F, Covelli C, Marra A, et al. T Helper Lymphocyte and Mast Cell Immunohistochemical Pattern in Nonceliac Gluten Sensitivity. Gastroenterol Res Pract. 2017;2017:5023680.
Uhde M, Ajamian M, Caio G, Giorgio RD, Indart A, Green PH, et al. Intestinal cell damage and systemic immune activation in individuals reporting sensitivity to wheat in the absence of coeliac disease. Gut. 2016 Dec 1;65(12):1930–7.
Volta U, De Giorgio R, Caio G, Uhde M, Manfredini R, Alaedini A. Nonceliac Wheat Sensitivity: An Immune-Mediated Condition with Systemic Manifestations. Gastroenterol Clin North Am. 2019 Mar;48(1):165–82.
Mumolo MG, Rettura F, Melissari S, Costa F, Ricchiuti A, Ceccarelli L, et al. Is Gluten the Only Culprit for Non-Celiac Gluten/Wheat Sensitivity? Nutrients. 2020 Dec;12(12):3785.
Herrera MG, Pizzuto M, Lonez C, Rott K, Hütten A, Sewald N, et al. Large supramolecular structures of 33-mer gliadin peptide activate toll-like receptors in macrophages. Nanomedicine Nanotechnol Biol Med. 2018 Jun 1;14(4):1417–27.
Hill P, Muir JG, Gibson PR. Controversies and Recent Developments of the Low-FODMAP Diet. Gastroenterol Hepatol. 2017 Jan;13(1):36–45.
Zevallos VF, Raker V, Tenzer S, Jimenez-Calvente C, Ashfaq-Khan M, Rüssel N, et al. Nutritional Wheat Amylase-Trypsin Inhibitors Promote Intestinal Inflammation via Activation of Myeloid Cells. Gastroenterology. 2017 Apr;152(5):1100-1113.e12.
Junker Y, Zeissig S, Kim SJ, Barisani D, Wieser H, Leffler DA, et al. Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4. J Exp Med. 2012 Dec 3;209(13):2395–408.
Schuppan D, Zevallos V. Wheat Amylase Trypsin Inhibitors as Nutritional Activators of Innate Immunity. Dig Dis. 2015;33(2):260–3.
Lebwohl B, Sanders DS, Green PHR. Coeliac disease. The Lancet. 2018 Jan 6;391(10115):70–81.
Bąk K. Celiakia – zasady diagnostyki według nowych wytycznych ESPGHAN 2020 (Internet). Medycyna.pl. 2021 (cited 2023 Mar 31). Available from: https://medycyna.pl/celiakia-zasady-diagnostyki-wedlug-nowych-wytycznych-espghan-2020/
Al-Toma A, Volta U, Auricchio R, Castillejo G, Sanders DS, Cellier C, et al. European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders. United Eur Gastroenterol J. 2019;7(5):583–613.
Celiakia (Internet). (cited 2023 Mar 31). Available from: http://www.mp.pl/social/chapter/B16.II.4.10.
Rej A, Aziz I, Sanders D s. Coeliac disease and noncoeliac wheat or gluten sensitivity. J Intern Med. 2020;288(5):537–49.
Vazquez-Roque M, Oxentenko AS. Nonceliac Gluten Sensitivity. Mayo Clin Proc. 2015 Sep 1;90(9):1272–7.
Catassi C, Elli L, Bonaz B, Bouma G, Carroccio A, Castillejo G, et al. Diagnosis of Non-Celiac Gluten Sensitivity (NCGS): The Salerno Experts’ Criteria. Nutrients. 2015 Jun;7(6):4966–77.
Kabbani TA, Vanga RR, Leffler DA, Villafuerte-Galvez J, Pallav K, Hansen J, et al. Celiac Disease or Non-Celiac Gluten Sensitivity? An Approach to Clinical Differential Diagnosis. Off J Am Coll Gastroenterol ACG. 2014 May;109(5):741.
Rubio-Tapia A, Hill ID, Kelly CP, Calderwood AH, Murray JA. ACG Clinical Guidelines: Diagnosis and Management of Celiac Disease. Off J Am Coll Gastroenterol ACG. 2013 May;108(5):656.
Shmidt E, Smyrk TC, Boswell CL, Enders FT, Oxentenko AS. Increasing duodenal intraepithelial lymphocytosis found at upper endoscopy: time trends and associations. Gastrointest Endosc. 2014 Jul 1;80(1):105–11.
https://www.mp.pl/pacjent/gastrologia/choroby/jelitocienkie/54362,celiakia
Matysiak–Budnik T, Candalh C, Cellier C, Dugave C, Namane A, Vidal–Martinez T, et al. Limited Efficiency of Prolyl-Endopeptidase in the Detoxification of Gliadin Peptides in Celiac Disease. Gastroenterology. 2005 Sep 1;129(3):786–96.
Matysiak–Budnik T, Candalh C, Cellier C, Dugave C, Namane A, Vidal–Martinez T, et al. Limited Efficiency of Prolyl-Endopeptidase in the Detoxification of Gliadin Peptides in Celiac Disease. Gastroenterology. 2005 Sep 1;129(3):786–96.
McCarville JL, Caminero A, Verdu EF. Pharmacological approaches in celiac disease. Curr Opin Pharmacol. 2015 Dec 1;25:7–12.
Leffler DA, Kelly CP, Green PHR, Fedorak RN, DiMarino A, Perrow W, et al. Larazotide Acetate for Persistent Symptoms of Celiac Disease Despite a Gluten-Free Diet: A Randomized Controlled Trial. Gastroenterology. 2015 Jun 1;148(7):1311-1319.e6.
Lähdeaho ML, Kaukinen K, Laurila K, Vuotikka P, Koivurova OP, Kärjä-Lahdensuu T, et al. Glutenase ALV003 attenuates gluten-induced mucosal injury in patients with celiac disease. Gastroenterology. 2014 Jun;146(7):1649–58.
Angelis MD, Rizzello CG, Fasano A, Clemente MG, Simone CD, Silano M, et al. VSL#3 probiotic preparation has the capacity to hydrolyze gliadin polypeptides responsible for Celiac Sprue probiotics and gluten intolerance. Biochim Biophys Acta BBA - Mol Basis Dis. 2006 Jan 1;1762(1):80–93.
Drago S, El Asmar R, Di Pierro M, Grazia Clemente M, Tripathi A, Sapone A, et al. Gliadin, zonulin and gut permeability: Effects on celiac and non-celiac intestinal mucosa and intestinal cell lines. Scand J Gastroenterol. 2006 Apr;41(4):408–19.
Paterson BM, Lammers KM, Arrieta MC, Fasano A, Meddings JB. The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in coeliac disease subjects: a proof of concept study. Aliment Pharmacol Ther. 2007 Sep 1;26(5):757–66.
Pinier M, Verdu EF, Nasser-Eddine M, David CS, Vézina A, Rivard N, et al. Polymeric binders suppress gliadin-induced toxicity in the intestinal epithelium. Gastroenterology. 2009 Jan;136(1):288–98.
Pinier M, Fuhrmann G, Verdu EF, Leroux JC. Prevention measures and exploratory pharmacological treatments of celiac disease. Am J Gastroenterol. 2010 Dec;105(12):2551–61; quiz 2562.
Reilly RM, Domingo R, Sandhu J. Oral delivery of antibodies. Future pharmacokinetic trends. Clin Pharmacokinet. 1997 Apr;32(4):313–23.
Siegel M, Khosla C. Transglutaminase 2 inhibitors and their therapeutic role in disease states. Pharmacol Ther. 2007 Aug;115(2):232–45.
Schuppan D, Junker Y, Barisani D. Celiac Disease: From Pathogenesis to Novel Therapies. Gastroenterology. 2009 Dec 1;137(6):1912–33.
Keech CL, Dromey J, Chen Z, Anderson RP, McCluskey J. Immune Tolerance Induced By Peptide Immunotherapy in An HLA Dq2-Dependent Mouse Model of Gluten Immunity. GASTROENTEROLOGY (Internet). 2009 (cited 2023 Mar 31);136(5). Available from: https://findanexpert.unimelb.edu.au/scholarlywork/930901-immune-tolerance-induced-by-peptide-immunotherapy-in-an-hla-dq2-dependent-mouse-model-of-gluten-immunity
Anderson RP, Jabri B. Vaccine against autoimmune disease: antigen-specific immunotherapy. Curr Opin Immunol. 2013 Jun 1;25(3):410–7.
Huibregtse IL, Marietta EV, Rashtak S, Koning F, Rottiers P, David CS, et al. Induction of Antigen-Specific Tolerance by Oral Administration of Lactococcus lactis Delivered Immunodominant DQ8-Restricted Gliadin Peptide in Sensitized Nonobese Diabetic Ab° Dq8 Transgenic Mice1. J Immunol. 2009 Aug 15;183(4):2390–6.
Senger S, Luongo D, Maurano F, Mazzeo MF, Siciliano RA, Gianfrani C, et al. Intranasal administration of a recombinant α-gliadin down-regulates the immune response to wheat gliadin in DQ8 transgenic mice. Immunol Lett. 2003 Aug 5;88(2):127–34.
Weinstock JV, Elliott DE. Helminths and the IBD Hygiene Hypothesis. Inflamm Bowel Dis. 2009 Jan 1;15(1):128–33.
Daveson AJ, Jones DM, Gaze S, McSorley H, Clouston A, Pascoe A, et al. Effect of Hookworm Infection on Wheat Challenge in Celiac Disease – A Randomised Double-Blinded Placebo Controlled Trial. PLOS ONE. 2011 Mar 8;6(3):e17366.
Silano M, Vincentini O, Iapello A, Mancini E, De Vincenzi M. Antagonist Peptides of the Gliadin T-cell Stimulatory Sequences: A Therapeutic Strategy for Celiac Disease. J Clin Gastroenterol. 2008 Sep;42:S191.
Anderson RP, Heel DA van, Tye-Din JA, Jewell DP, Hill AVS. Antagonists and non-toxic variants of the dominant wheat gliadin T cell epitope in coeliac disease. Gut. 2006 Apr 1;55(4):485–91.
Targeting interleukin‐15 in patients with rheumatoid arthritis: A proof‐of‐concept study. (cited 2023 Apr 2); Available from: https://onlinelibrary.wiley.com/doi/10.1002/art.21249
Rossi M, Maurano F, Luongo D. Immunomodulatory Strategies for Celiac Disease. Int Rev Immunol. 2005 Jan 1;24(5–6):479–99.
Hüe S, Mention JJ, Monteiro RC, Zhang S, Cellier C, Schmitz J, et al. A Direct Role for NKG2D/MICA Interaction in Villous Atrophy during Celiac Disease. Immunity. 2004 Sep 1;21(3):367–77.
Zhao J, Vera J de, Narushima S, Beck EX, Palencia S, Shinkawa P, et al. R-spondin1, A Novel Intestinotrophic Mitogen, Ameliorates Experimental Colitis in Mice. Gastroenterology. 2007 Apr 1;132(4):1331–43.
Tuck CJ, Biesiekierski JR, Schmid-Grendelmeier P, Pohl D. Food Intolerances. Nutrients. 2019 Jul;11(7):1684.
Biesiekierski JR, Peters SL, Newnham ED, Rosella O, Muir JG, Gibson PR. No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates. Gastroenterology. 2013 Aug 1;145(2):320-8.e1-3.
Skodje GI, Sarna VK, Minelle IH, Rolfsen KL, Muir JG, Gibson PR, et al. Fructan, Rather Than Gluten, Induces Symptoms in Patients With Self-Reported Non-Celiac Gluten Sensitivity. Gastroenterology. 2018 Feb 1;154(3):529-539.e2.
Barone M, Gemello E, Viggiani MT, Cristofori F, Renna C, Iannone A, et al. Evaluation of Non-Celiac Gluten Sensitivity in Patients with Previous Diagnosis of Irritable Bowel Syndrome: A Randomized Double-Blind Placebo-Controlled Crossover Trial. Nutrients. 2020 Mar;12(3):705.
Barbaro MR, Cremon C, Wrona D, Fuschi D, Marasco G, Stanghellini V, et al. Non-Celiac Gluten Sensitivity in the Context of Functional Gastrointestinal Disorders. Nutrients. 2020 Dec;12(12):3735.
Cárdenas-Torres FI, Cabrera-Chávez F, Figueroa-Salcido OG, Ontiveros N. Non-Celiac Gluten Sensitivity: An Update. Medicina (Mex). 2021 Jun;57(6):526.
Roncoroni L, Bascuñán KA, Vecchi M, Doneda L, Bardella MT, Lombardo V, et al. Exposure to Different Amounts of Dietary Gluten in Patients with Non-Celiac Gluten Sensitivity (NCGS): An Exploratory Study. Nutrients. 2019 Jan;11(1):136.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Kacper Kulik, Zuzanna Fryska, Adam Wołejko, Jakub Kuciński, Paweł Semeniuk, Krystian Matusz, Rafał Burczyk, Natalie Górna, Adam Łabuda
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 516
Number of citations: 0
